Taiwan Grants Full Approval for NEFECON IgAN Treatment
Everest Medicines, a biopharmaceutical company dedicated to advancing innovative therapies, has announced that Taiwan’s Food and Drug Administration (TFDA) has granted full approval for...
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
Aptar Pharma, a global leader in drug delivery and active material science solutions and services, announced its acquisition of the clinical trial materials manufacturing...
FDA Accepts BLA for Recommended Biosimilar to Simponi
Bio-Thera Solutions announced that the FDA has accepted its Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi® (golimumab). The FDA goal...
FDA Approves Oral Therapy for Treating Hereditary Angioedema
The US Food and Drug Administration (FDA) has approved the first on-demand oral therapy for the treatment of acute attacks of hereditary angioedema (HAE)...
Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced on June 5 2025, that LUMRYZTM has been granted Orphan...
Stringent Policy around COVID Vaccines Laid by FDA
The US FDA is now tightening its regulatory policy around COVID vaccines by setting up a new framework that raises the bar for certain...
Global Biopharma Market to Hit $566B by 2032
Global Biopharma Market Forecasts $566B By 2032 opposing Challenges
With a compound annual growth rate of almost 8%, from $263 billion in 2022 to $566...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...